Join Growin Stock Community!

天良4127.TW Overview

TW StockBiotech. & Medical
(No presentation for 4127)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

天良（4127）Overall Performance

天良（4127）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

天良（4127） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

天良（4127）Key Information

天良（4127）Profile

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, low back pain, sore feet, dizziness, thirst, dry tongue, sore throat, and heel pain, as well as rheumatism, joint pain, traveling pain, wind-cold-dampness, gout, neuralgia, enuresis, hemorrhoids, constipation, athlete's foot, fall injuries, cold, bronchitis, cough, and phlegm indications. It provides western medicine products, including ointment, hair removal cream, tablet, capsule, soreness spray, and pain patch products, as well as pain relief gels. In addition, the company offers healthcare products; and other products for body relaxation and comfort, and relieving discomfort after exercise, as well as tooth products and soaps. The company was founded in 1960 and is based in New Taipei City, Taiwan.

天良（4127）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
56.26%
Net Margin
-0.70%
Revenue Growth (YoY)
6.18%
Profit Growth (YoY)
-2.79%
3-Year Revenue Growth
3.24%
3-Year Profit Growth
-2.62%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
56.26%
Net Margin
-0.70%
Revenue Growth (YoY)
6.18%
Profit Growth (YoY)
-2.79%
3-Year Revenue Growth
3.24%
3-Year Profit Growth
-2.62%
default symbol

4127

天良

36.20D

-1.66%

(-0.02)

  • When is 4127's latest earnings report released?

    The most recent financial report for 天良 (4127) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4127's short-term business performance and financial health. For the latest updates on 4127's earnings releases, visit this page regularly.

  • What is the operating profit of 4127?

    According to the latest financial report, 天良 (4127) reported an Operating Profit of 2.73M with an Operating Margin of 2% this period, representing a growth of 18.17% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4127's revenue growth?

    In the latest financial report, 天良 (4127) announced revenue of 136.22M, with a Year-Over-Year growth rate of 40.36%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4127 have?

    At the end of the period, 天良 (4127) held Total Cash and Cash Equivalents of 196.01M, accounting for 0.16 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4127 go with three margins increasing?

    In the latest report, 天良 (4127) achieved the “three margins increasing” benchmark, with a gross margin of 54.85%%, operating margin of 2%%, and net margin of 17.16%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4127's profit trajectory and future growth potential.

  • Is 4127's EPS continuing to grow?

    According to the past four quarterly reports, 天良 (4127)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.51. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4127?

    天良 (4127)'s Free Cash Flow (FCF) for the period is 118.35M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 2,873.57% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.